title: Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

text: L 60/16 EN Official Journal of the European Communities 9. 3. 1999 COMMISSION REGULATION (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin THE COMMISSION OF THE EUROPEAN COMMUNITIES, Having regard to the Treaty establishing the European Community, Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veter- inary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 2728/98 (2), and in particular Articles 6, 7 and 8 thereof, Whereas, since the adoption of Regulation (EEC) No 2377/90, the Annexes have been amended a number of times; whereas, since the texts are numerous, complex and dispersed among various Official Journals, they are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, certain of those Annexes should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected; Whereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products, HAS ADOPTED THIS REGULATION: Article 1 Annexes I to IV to Regulation (EEC) No 2377/90 are hereby replaced by the texts set out in the Annex to this Regulation. Article 2 This Regulation shall enter into force on the 60th day following that of its publication in the Official Journal of the European Communities. This Regulation shall be binding in its entirety and directly applicable in all Member States. Done at Brussels, 4 March 1999. For the Commission Martin BANGEMANN Member of the Commission (1) OJ L 224, 18. 8. 1990, p. 1. (2) OJ L 343, 18. 12. 1998, p. 8. LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED ANNEX I Anti-infectious agents Chemotheurapeutics 1. 1. 1. 1. 1. 1. Sulfonamides Pharmacologically active substance(s) All substances belonging to the sulfonamide group Marker residue Animal species MRLs Target tissues Other provisions Parent drug All food-producing species Bovine, ovine, caprine 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney 100 lg/kg Milk Fat Liver The combined total residues of all substances within the sulfonamide group should not exceed 100 lg/kg 1. 1. 2. Diamino pyrimidine derivatives Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Baquiloprim Baquiloprim Bovine Porcine Trimethoprim Trimethoprim Bovine Porcine Equidae Fat Liver 10 lg/kg 300 lg/kg 150 lg/kg Kidney 30 lg/kg Milk 40 lg/kg 50 lg/kg 50 lg/kg Kidney Skin and fat Liver Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 50 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney Fat Liver Skin and fat Liver 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 1 7 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Poultry Not for use in animals from which eggs are produced for human consumption Fin fish 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 50 lg/kg Muscle and Skin and fat Liver skin in natural proportions 1. 2. Antibiotics 1. 2. 1. Penicillins Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Amoxicyllin Amoxicyllin All food-producing species Ampicillin Ampicillin All food-producing species Benzylpenicillin Benzylpenicillin All food-producing species Cloxacillin Cloxacillin All food-producing species 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 4 lg/kg Milk Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 4 lg/kg Milk Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 4 lg/kg Milk Fat Liver 300 lg/kg Muscle 300 lg/kg 300 lg/kg 300 lg/kg Kidney 30 lg/kg Milk Fat Liver L 6 0 / 1 8 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Dicloxacillin Dicloxacillin All food-producing species Oxacillin Oxacillin All food-producing species Penethamate Benzylpenicillin Bovine 300 lg/kg Muscle 300 lg/kg 300 lg/kg 300 lg/kg Kidney 30 lg/kg Milk Fat Liver 300 lg/kg Muscle 300 lg/kg 300 lg/kg 300 lg/kg Kidney 30 lg/kg Milk Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 4 lg/kg Milk Fat Liver 1. 2. 2. Cephalosporins Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Cefazolin Cefazolin Bovine, ovine, caprine 50 lg/kg Milk Cefquinome Cefquinome Bovine 50 lg/kg Muscle 50 lg/kg 100 lg/kg 200 lg/kg Kidney 20 lg/kg Milk Fat Liver 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 1 9 1. 2. 3. Quinolones Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Danofloxacin Danofloxacin Bovine Not for use in animals from which milk is produced for human consumption Chicken Not for use in animals from which eggs are produced for human consumption Fat Liver 200 lg/kg Muscle 100 lg/kg 400 lg/kg 400 lg/kg Kidney 200 lg/kg Muscle 100 lg/kg 400 lg/kg 400 lg/kg Kidney Skin and fat Liver Difloxacin Difloxacin Chicken, turkey 300 lg/kg Muscle 400 lg/kg 1 900 lg/kg Skin and fat Liver 600 lg/kg Kidney Enrofloxacin Sum of enrofloxacin and ciprofloxacin Bovine Rabbits Porcine Poultry Not for use in animals from which eggs are produced for human consumption Fat Liver Fat Liver 100 lg/kg Muscle 100 lg/kg 300 lg/kg 200 lg/kg Kidney 100 lg/kg Milk 100 lg/kg Muscle 100 lg/kg 200 lg/kg 300 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 200 lg/kg 300 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 200 lg/kg 300 lg/kg Kidney Skin and fat Liver Skin and fat Liver L 6 0 / 2 0 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Sarafloxacin Sarafloxacin Chicken Salmonidae 10 lg/kg 100 lg/kg 30 lg/kg Muscle and Skin and fat Liver skin in natural proportions 1. 2. 4. Macrolides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Spiramycin Sum of spiramycin and neospiramycin Bovine Chicken Tilmicosin Tilmicosin Bovine, ovine, porcine Ovine Chicken Tylosin Tylosin A Bovine Fat Liver 200 lg/kg Muscle 300 lg/kg 300 lg/kg 300 lg/kg Kidney 200 lg/kg Milk 200 lg/kg Muscle 300 lg/kg 400 lg/kg Skin and fat Liver Fat Liver 50 lg/kg Muscle 50 lg/kg 1 000 lg/kg 1 000 lg/kg Kidney 50 lg/kg Milk 75 lg/kg Muscle 75 lg/kg 1 000 lg/kg Skin and fat Liver 250 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney 50 lg/kg Milk Fat Liver Not for use in animals from which eggs are produced for human consumption 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 2 1 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Porcine Poultry Not for use in hens producing eggs for human consumption Skin and fat Liver 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney Skin and fat Liver 1. 2. 5. Florfenicol and related compounds Pharmacologically active substance(s) Florfenicol Marker residue Animal species MRLs Target tissues Other provisions Sum of florfenicol and its metabolites measured as florfenicol-amine Bovine 200 lg/kg Muscle 3 000 lg/kg Liver 300 lg/kg Kidney Thiamphenicol Thiamphenicol Bovine Chicken Not for use in animals from which eggs are produced for human consumption Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 50 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney Skin and fat Liver 1. 2. 6. Tetracyclines Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Chlortetracycline Sum of parent drug and All food-producing species its 4- epimer Liver 100 lg/kg Muscle 300 lg/kg 600 lg/kg Kidney 100 lg/kg Milk Eggs 200 lg/kg L 6 0 / 2 2 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Doxycycline Doxycycline Bovine Not for use in animals from which milk is produced for human consumption Porcine Poultry Not for use in animals from which eggs are produced for human consumption Oxytetracycline Sum of parent drug and All food-producing species its 4-epimer Tetracycline Sum of parent drug and All food-producing species its 4-epimer Skin and fat Liver Skin and fat Liver Liver 100 lg/kg Muscle 300 lg/kg 600 lg/kg Kidney 100 lg/kg Muscle 300 lg/kg 300 lg/kg 600 lg/kg Kidney 100 lg/kg Muscle 300 lg/kg 300 lg/kg 600 lg/kg Kidney Liver 100 lg/kg Muscle 300 lg/kg 600 lg/kg Kidney 100 lg/kg Milk Eggs 200 lg/kg Liver 100 lg/kg Muscle 300 lg/kg 600 lg/kg Kidney 100 lg/kg Milk Eggs 200 lg/kg 1. 2. 7. Naphtalene-ringed ansamycin Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Rifaximin Rifaximin Bovine 60 lg/kg Milk 1. 2. 8. Pleuromutilines Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Valnemulin Valnemulin Porcine 50 lg/kg Muscle 500 lg/kg 100 lg/kg Kidney Liver 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 2 3 Antiparasitic agents Agents acting against endoparasites 2. 2. 1. 2. 1. 1. Salicylanilides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Closantel Closantel Bovine Ovine Fat Liver 1 000 lg/kg Muscle 3 000 lg/kg 1 000 lg/kg 3 000 lg/kg Kidney 1 500 lg/kg Muscle 2 000 lg/kg 1 500 lg/kg 5 000 lg/kg Kidney Fat Liver 2. 1. 2. Tatra-hydro-imidazoles (imidazolthiazoles) Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Levamisole Levamisole Bovine, ovine, porcine, poultry 10 lg/kg Muscle 10 lg/kg 100 lg/kg 10 lg/kg Kidney Fat Liver 2. 1. 3. Benzimidazoles and pro-benzimidazoles Marker residue Animal species MRLs Target tissues Other provisions Pharmacologically active substance(s) Albendazole Bovine, ovine albendazole Sum of sulphoxide, albendazole sulphone, and albenda- zole 2-amino sulphone, expressed as albendazole Febantel Sum of extractable resi- be dues which may oxidised to oxfendazole Bovine, ovine Bovine, ovine, porcine, equidae 100 lg/kg Muscle 100 lg/kg 1 000 lg/kg Fat Liver 500 lg/kg Kidney 100 lg/kg Milk 10 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 500 lg/kg 50 lg/kg Kidney Fat Liver L 6 0 / 2 4 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Fenbendazole Marker residue Animal species MRLs Target tissues Other provisions Sum of extractable resi- dues which may be oxidised to oxfendazole sulphone Bovine, ovine Bovine, ovine, porcine, equide 10 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 500 lg/kg 50 lg/kg Kidney Fat Liver Flubendazole Oxfendazole Sum of flubendazole and (2-amino 1H-benzimida- zol-5-yl) (4fluorophenyl) methanone Porcine, chicken, game birds Flubendazole Chicken Sum of extractable resi- dues which may be oxidised to oxfendazole sulphone Bovine, ovine Bovine, ovine, porcine, equidae Oxibendazole Oxibendazole Porcine Thiabendazole Sum of thiabendazole and 5-hydroxythiabenda- zole Bovine Triclabendazole Sum of extractable resi- dues be that may oxidised to ketotricla- bendazole Bovine, ovine 50 lg/kg Muscle 50 lg/kg 400 lg/kg 300 lg/kg Kidney 400 lg/kg Eggs Skin and fat Liver 10 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 500 lg/kg 50 lg/kg Kidney Fat Liver 100 lg/kg Muscle 500 lg/kg 200 lg/kg 100 lg/kg Kidney Skin and fat Liver 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney 100 lg/kg Milk Fat Liver 100 lg/kg Muscle 100 lg/kg 100 lg/kg Kidney Liver Not for use in animals from which milk is produced for human consumption 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 2 5 2. 2. Agents acting against ectoparasites 2. 2. 1. Organophosphates Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Diazinon Diazinon Bovine, ovine, caprine Bovine, porcine, ovine, caprine 20 lg/kg Milk 20 lg/kg Muscle 700 lg/kg 20 lg/kg 20 lg/kg Kidney Fat Liver 2. 2. 2. Formamidines Pharmacologically active substance(s) Amitraz 2. 2. 3. Pyrethroids Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Sum of amitraz and all metabolites containing the 2,4-DMA moiety, expressed as amitraz Bovine Ovine Porcine Fat Liver 200 lg/kg 200 lg/kg 200 lg/kg Kidney 10 lg/kg Milk 400 lg/kg 100 lg/kg 200 lg/kg Kidney 10 lg/kg Milk 400 lg/kg 200 lg/kg 200 lg/kg Kidney Fat Liver Skin and fat Liver Marker residue Animal species MRLs Target tissues Other provisions Flumethrin Flumethrin trans-Z isomers) (sum of Bovine 10 lg/kg Muscle 150 lg/kg 20 lg/kg 10 lg/kg Kidney 30 lg/kg Milk Fat Liver L 6 0 / 2 6 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 2. 3. Agents acting against endo- and ectoparasites 2. 3. 1. Avermectins Phramacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Abamectin Avermectin B1a Bovine 10 lg/kg 20 lg/kg Fat Liver Not for use in bovine from which milk is produced for human consumption for use in ovine from which milk is Not produced for human consumption Doramectin Doramectin Bovine Porcine, ovine Eprinomectin Eprinomectin B1a Bovine Ivermectin 23-Dihydro-aver- 22, mectin B1a Bovine Porcine, ovine, equidae Deer, including reindeer Fat Liver 10 lg/kg Muscle 150 lg/kg 100 lg/kg 30 lg/kg Kidney 20 lg/kg Muscle 100 lg/kg 50 lg/kg 30 lg/kg Kidney Fat Liver 30 lg/kg Muscle 30 lg/kg 600 lg/kg 100 lg/kg Kidney 30 lg/kg Milk Fat Liver Fat Liver Fat Liver 40 lg/kg 100 lg/kg 20 lg/kg 15 lg/kg 20 lg/kg Muscle 100 lg/kg 50 lg/kg 20 lg/kg Kidney Fat Liver Moxidectin Moxidectin Bovine, ovine 50 lg/kg Muscle 500 lg/kg 100 lg/kg 50 lg/kg Kidney Fat Liver 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 2 7 2. 4. Agents acting against protozoa 2. 4. 1. Triazinetrione derivative Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Toltrazuril Toltrazuril sulfone Chicken Turkey 3. Agents acting on the nervous system 3. 1. Agents acting on the central nervous system 3. 1. 1. Butyrophenone tranquillisers Not for use in animals from which eggs are produced for human consumption Skin and fat Liver 100 lg/kg Muscle 200 lg/kg 600 lg/kg 400 lg/kg Kidney 100 lg/kg Muscle 200 lg/kg 600 lg/kg 400 lg/kg Kidney Skin and fat Liver Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Azaperone Sum of azaperone and azaperol Porcine 100 lg/kg Muscle 100 lg/kg 100 lg/kg 100 lg/kg Kidney Skin and fat Liver 3. 2. Agents acting on the autonomic nervous system 3. 2. 1. Anti-adrenergics Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Carazolol Carazolol Porcine 5 lg/kg Muscle 5 lg/kg 25 lg/kg 25 lg/kg Kidney Skin and fat Liver L 6 0 / 2 8 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Anti-inflammatory agents 4. 4. 1. Nonsteroidal anti-inflammatory agents 4. 1. 1. Arylpropionic acid derivative Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Vedaprofen Vedaprofen Equidae 50 lg/kg Muscle 20 lg/kg 100 lg/kg Fat Liver 1 000 lg/kg Kidney 4. 1. 2. Fenamate group derivatives Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Tolfenamic acid Tolfenamic acid Bovine Porcine Liver 50 lg/kg Muscle 400 lg/kg 100 lg/kg Kidney 50 lg/kg Milk 50 lg/kg Muscle 400 lg/kg 100 lg/kg Kidney Liver 5. 5. 1. Corticoides Glucocorticoides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Dexamethasone Dexamethasone Bovine Bovine, porcine, equidae 0,3 lg/kg Milk 0,75 lg/kg Muscle 2 lg/kg Liver 0,75 lg/kg Kidney 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 2 9 LIST OF SUBSTANCES NOT SUBJECT TO MAXIMUM RESIDUE LIMITS ANNEX II 1. Inorganic chemicals Pharmacologically active substance(s) Animal species Other provisions Aluminium distearate All food-producing species Aluminium hydroxide acetate All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species For oral use only All food-producing species For oral use only All food-producing species For oral use only All food-producing species For oral use only All food-producing species All mammalian food-producing species For topical use only All food-producing species Aluminium phosphate Aluminium tristearate Ammonium chloride Bismuth subcarbonate Bismuth subgallate Bismuth subnitrate Bismuth subsalicylate Boric acid and borates Bromide, sodium salt Calcium acetate Calcium benzoate Calcium carbonate Calcium chloride Calcium gluconate Calcium hydroxide Calcium hypophosphite Calcium malate Calcium oxide Calcium phosphate Calcium polyphosphates Calcium propionate Calcium silicate Calcium stearate Calcium sulphate L 6 0 / 3 0 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions Calcium glucoheptonate Calcium glucono glucoheptonate Calcium gluconolactate Calcium glutamate Cobalt carbonate Cobalt dichloride Cobalt gluconate Cobalt oxide Cobalt sulphate Cobalt trioxide Copper chloride Copper gluconate Copper heptanoate Copper methionate Copper oxide Copper sulphate Dicopper oxide Hydrochloric acid Hydrogen peroxide Iodine and iodine inorganic compounds including: — Sodium and potassium-iodide — Sodium and potassium-iodate — Iodophors including polyvinylpyrrolidone-iodine Iron dichloride Iron sulphate All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species For use as excipient All food-producing species All food-producing species All food-producing species All food-producing species 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 3 1 Pharmacologically active substance(s) Animal species Other provisions Magnesium Magnesium sulphate Magnesium hydroxide Magnesium stearate Magnesium glutamate Magnesium orotate Magnesium aluminium silicate Magnesium oxide Magnesium carbonate Magnesium phosphate Magnesium glycerophosphate Magnesium aspartate Magnesium citrate Magnesium acetate Magnesium trisilicate Nickel gluconate Nickel sulphate Potassium DL-aspartate Potassium glucuronate Potassium glycerophosphate Potassium nitrate Potassium selenate Sodium chlorite Sodium dichloroisocyanurate Sodium hypophosphite Sodium selenate Sodium selenite Sulphur Zinc acetate Zinc chloride Zinc gluconate Zinc oleate Zinc stearate All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Bovine Bovine, ovine, caprine All food-producing species All food-producing species All food-producing species Bovine, porcine, ovine, caprine, equidae All food-producing species For topical use only For topical use only L 6 0 / 3 2 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 2. Organic compounds Pharmacologically active substance(s) Animal species Other provisions 17b-Oestradiol 2-Aminoethanol All mammalian food-producing species For therapeutic and zootechnical uses only All food-producing species 2-Aminoethyl dihydrogenphosphate All food-producing species 2-Pyrrolidone 8-Hydroxyquinoline Acetyl cysteine Alfacalcidol Alfaprostol Bacitracin All food-producing species At parenteral doses up to 40 mg/kg bw All mammalian food-producing species For topical use in newborn animals only All food-producing species Bovine For parturient cows only Rabbits Bovine, porcine, equidae Bovine For intramammary use in lactating cows only and for all tissues except milk Benzalkonium chloride All food-producing species For use as an excipient at concentrations up to 0,05 % only Benzocaine Benzylalcohol Betaine Bronopol Brotizolam Buserelin All food-producing species For use as local anaesthetic only All food-producing species For use as excipient All food-producing species Salmonidae Bovine All food-producing species For use only on farmed fertilised eggs For therapeutic uses only Butorphanol tartrate Equidae For intravenous administration only Butyl 4-hydroxybenzoate All food-producing species 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 3 3 Pharmacologically active substance(s) Animal species Other provisions Butylscopolaminium bromide Caffeine Carbetocin Cefazolin Cetostearyl alcohol Cetrimide Chlorhexidine Chlorocresol Clazuril Cloprostenol All food-producing species All food-producing species All mammalian food-producing species Bovine Ovine, caprine All food-producing species All food-producing species For intramammary use, except if the udder may be used as food for human consumption All food-producing species For topical use only All food-producing species Pigeon Bovine, porcine, equidae Coco alkyl dimethyl betaines All food-producing species For use as excipient Corticotropin All food-producing species D-Phe 6 -luteinising-hormone releasing hormone All food-producing species Dembrexine Denaverine hydrochloride Detomidine Diclazuril Diethyl phtalate Equidae Bovine Bovine, equidae Ovine All food-producing species For therapeutic uses only For oral use in lambs only Diethylene glycol monoethyl ether Bovine, porcine Dimanganese trioxide Dimethyl phtalate Dinoprost All food-producing species For oral use only All food-producing species All mammalian food-producing species Dinoprost tromethamine All mammalian food-producing species L 6 0 / 3 4 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions Diprophylline Etamiphylline camsylate Ethanol Ethyl lactate Etiproston tromethamine Fertirelin acetate Flumethrin Folic acid Glycerol formal All food-producing species All food-producing species All food-producing species For use as excipient All food-producing species Bovine, porcine Bovine Bees (honey) All food-producing species All food-producing species Gonadotrophin releasing hormone All food-producing species Heptaminol Hesperidin Hesperidin methyl chalcone Hexetidine All food-producing species Equidae Equidae Equidae Human chorion gonadotrophin All food-producing species Human menopausal urinary gonadotrophin Bovine For topical use only Hydrocortisone Iodine organic compounds — Iodoform Isobutane Isoflurane Isoxsuprine Ketamine All food-producing species For topical use only All food-producing species All food-producing species Equidae Bovine, equidae All food-producing species For use as anaesthetic only For therapeutic use only in accordance with Council Directive 96/22/EEC (OJ L 125, 23. 5. 1996, p. 3) Ketanserin tartrate Equidae 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 3 5 Pharmacologically active substance(s) Animal species Other provisions Ketoprofen Bovine, porcine, equidae L-tartaric acid and its mono- and di-basic salt of sodium, potassium and calcium All food-producing species For use as excipient Lactic acid Lecirelin Lobeline Luprostiol Malic acid Manganese carbonate Manganese chloride Manganese gluconate Manganese glycerophosphate Manganese oxide Manganese pidolate Manganese ribonucleate Manganese sulphate Mecillinam Medroxyprogesterone acetate Melatonin Menadione Menbutone Menthol All food-producing species Bovine, equidae, rabbits All food-producing species All mammalian species All food-producing species For use as excipient For oral use only For oral use only For oral use only For oral use only For oral use only For oral use only For oral use only For oral use only For intrauterine use only For intravaginal use for zootechnical purposes only All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Bovine Ovine Ovine, caprine All food-producing species Bovine, ovine, caprine, porcine, equidae All food-producing species Methyl nicotinate Bovine, equidae For topical use only Mineral hydrocarbons, low to high viscosity including microcristal- line waxes, approximately C10-C60; aliphatic, branched aliphatic and alicyclic compounds All food-producing species Excludes aromatic and unsaturated compounds L 6 0 / 3 6 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions N-butane N-butanol Natamycin Neostigmine Nicoboxil Nonivamide Oleyloleate Oxytocin Pancreatin Papain Papaverine Peracetic acid Phenol Phloroglucinol Phytomenadione Policresulen All food-producing species All food-producing species For use as excipient Bovine, equidae For topical use only All food-producing species Equidae Equidae For topical use only For topical use only All food-producing species For topical use only All mammalian food-producing species All mammalian food-producing species For topical use only All food-producing species Bovine Newborn calves only All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species For topical use only Polyethylene glycol 15 hydroxystearate All food-producing species For use as excipient Polyethylene glycol 7 glyceryl cocoate All food-producing species For topical use only Polyethylene glycol stearates with 8-40 oxyethylene units All food-producing species For use as excipient Polysulphated glycosaminoglycan Equidae 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 3 7 Pharmacologically active substance(s) Animal species Other provisions Praziquantel Ovine Equidae For use in non-lactating sheep only Pregnant mare serum gonadotrophin All food-producing species Prethcamide (crotethamide and cropropamide) All mammalian food-producing species Procaine Propane Propylene glycol Quatresin R-Cloprostenol Rifaximin Romifidine All food-producing species All food-producing species All food-producing species All food-producing species For use as preservative only at concentrations of up to 0,5 % Bovine, porcine, equidae All mammalian food-producing species For topical use only Bovine Equidae For intramammary use, except if the udder may be used as food for human consumption For therapeutic uses only Sodium 2-methyl-2-phenoxy-propanoate Bovine, porcine, caprine, equidae Sodium benzyl 4-hydroxybenzoate All food-producing species Sodium butyl 4-hydroxybenzoate All food-producing species Sodium cetostearyl sulphate All food-producing species For topical use only Somatosalm Tanninum Tau fluvalinate Terpin hydrate Tetracaine Salmon All food-producing species Bovine, porcine, ovine, caprine All food-producing species For use as anaesthetic only L 6 0 / 3 8 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions Theobromine Theophylline Thiomersal Thymol Timerfonate Trimethylphloroglucinol Vitamin D Wool alcohols All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species For use only as preservatives in multidose vaccines at a concentra- tion not exceeding 0,02 % For use only as preservatives in multidose vaccines at a concentra- tion not exceeding 0,02 % All food-producing species For topical use only 3. Substances generally recognised as safe Pharmacologically active substance(s) Animal species Other provisions Absinthium extract Acetylmethionine Aluminium hydroxide Aluminium monostearate Ammonium sulfate Benzoyl benzoate Benzyl p-hydroxybenzoate Calcium borogluconate Calcium citrate Camphor Cardamon extract Diethyl sebacate Dimethicone All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species External use only All food-producing species All food-producing species All food-producing species 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 3 9 Pharmacologically active substance(s) Animal species Other provisions Dimethyl acetamide Dimethyl sulphoxide Epinephrine Ethyl oleate All food-producing species All food-producing species All food-producing species All food-producing species Ethylenediaminetetraacetic acid and salts All food-producing species Eucalyptol All food-producing species Follicle stimulating hormone (natural FSH from all species and their synthetic analogues) All food-producing species Formaldehyde Formic acid Glutaraldehyde Guaiacol Heparin and its salts All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Human chorionic gonadotropin (natural HCG and its synthetic analogues) All food-producing species Iron ammonium citrate Iron dextran Iron glucoheptonate Isopropanol Lanolin All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Luteinising hormone (natural LH from all species and their synthetic analogues) All food-producing species Magnesium chloride Magnesium gluconate All food-producing species All food-producing species L 6 0 / 4 0 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions (molecular weight ranging from 200 to All food-producing species Magnesium hypophosphite Mannitol Methylbenzoate Monothioglycerol Montanide Myglyol Orgotein Poloxalene Poloxamer Polyethylene glycols 10 000) Polysorbate 80 Serotonin Sodium chloride Sodium cromoglycate Sodium dioctylsulphosuccinate Sodium formaldehydesulphoxylate Sodium lauryl sulphate Sodium pyrosulphite Sodium stearate Sodium thiosulphate Tragacanth Urea Zinc oxide Zinc sulphate All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 4 1 4. Substances used in homeopathic veterinary medicinal products Pharmacologically active substance(s) Animal species Other provisions All substances used in homeopathic veterinary medicinal products provided that their concentration in the product does not exceed one part per ten thousand All food-producing species 5. Substances used as food additives in foodstuffs for human consumption Pharmacologically active substance(s) Animal species Other provisions Substances with an E number All food-producing species Only substances approved as additives in foodstuffs for human consumption, with the exception of preservatives listed in part C of Annex III to European Parliament and Council Directive 95/2/EC (OJ L 61, 18. 3. 1995, p. 1). 6. Substances of vegetable origin Pharmacologically active substance(s) Animal species Other provisions Angelicae radix aetheroleum Anisi aetheroleum Balsamum peruvianum Carvi aetheroleum Caryophylli aetheroleum All food-producing species All food-producing species All food-producing species For topical use only All food-producing species All food-producing species Chrysanthemi cinerariifolii flos All food-producing species For topical use only Cinnamomi cassiae aetheroleum All food-producing species Cinnamomi ceylanici aetheroleum All food-producing species Citri aetheroleum Citronellae aetheroleum Coriandri aetheroleum Echinacea purpurea Eucalypti aetheroleum Foeniculi aetheroleum All food-producing species All food-producing species All food-producing species All food-producing species For topical use only All food-producing species All food-producing species L 6 0 / 4 2 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Animal species Other provisions Hamamelis virginiana Hyperici oleum Lespedeza capitata Lini oleum Majoranae herba Matricariae flos For topical use only For topical use only All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Medicago sativa extractum All food-producing species For topical use only Melissae folium All food-producing species Menthae piperitae aetheroleum All food-producing species Millefolii herba Myristicae aetheroleum All food-producing species All food-producing species For use in newborn animals only Oxidation products of Terebinthinae oleum Bovine, porcine, ovine, caprine Pyrethrum extract Quercus cortex Quillaia saponins Ricini oleum Rosmarini aetheroleum Rosmarini folium Salviae folium Sambuci flos Sinapis nigrae semen All food-producing species For topical use only All food-producing species All food-producing species All food-producing species For use as excipient All food-producing species All food-producing species All food-producing species All food-producing species All food-producing species Terebinthinae aetheroleum rectificatum All food-producing species For topical use only 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 4 3 Pharmacologically active substance(s) Animal species Other provisions Terebinthinae laricina Thymi aetheroleum Tiliae flos Urticae herba All food-producing species For topical use only All food-producing species All food-producing species All food-producing species L 6 0 / 4 4 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED ANNEX III Anti-infectious agents Chemotheurapeutics 1. 1. 1. 1. 1. 2. Benzenesulphonamides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Clorsulon Clorsulon Bovine 50 lg/kg Muscle 150 lg/kg 400 lg/kg Kidney Liver Provisional MRLs expire on 1 January 2000 Antibiotics 1. 2. 1. 2. 1. Beta-lactamase inhibitors Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Clavulanic acid Clavulanic acid Bovine, ovine Bovine, ovine, porcine Provisional MRLs expire on 1 July 1999 200 lg/kg Milk 200 lg/kg Muscle 200 lg/kg 200 lg/kg 200 lg/kg Kidney Fat Liver Marker residue Animal species MRLs Target tissues Other provisions 1. 2. 2. Macrolides Pharmacologically active substance(s) Erythromycin MRLs apply to all micro- biological active residues expressed erythro- as mycin equivalent Bovine, ovine Bovine, ovine, porcine, poultry Josamycin Josamycin Poultry Chicken Provisional MRLs expire on 1 June 2000 Provisional MRLs expire on 1 July 2000 40 lg/kg Milk 400 lg/kg Muscle 400 lg/kg 400 lg/kg 400 lg/kg Kidney 200 lg/kg Fat Liver Eggs 200 lg/kg Muscle 200 lg/kg 200 lg/kg 400 lg/kg Kidney 200 lg/kg Fat Liver Eggs 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 4 5 1. 2. 5. Aminoglycosides Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Aminosidine Aminosidine Bovine, porcine, rabbits, chicken 500 lg/kg Muscle 1 500 lg/kg 1 500 lg/kg Kidney Liver Provisional MRLs expire on 1 July 2000 Apramycin Apramycin Bovine For use in non-lactating cattle only Porcine Dihydrostreptomycin Dihydrostreptomycin Bovine, ovine Bovine, ovine, porcine, poultry Gentamicin Gentamicin Bovine Bovine, porcine Neomycin (including framycetin) Neomycin Bovine, ovine, caprine Bovine, ovine, caprine, porcine, chicken, turkey, duck Chicken Fat Liver 1 000 lg/kg Muscle 1 000 lg/kg 10 000 lg/kg 20 000 lg/kg Kidney 1 000 lg/kg Muscle 1 000 lg/kg 1 000 lg/kg 5 000 lg/kg Kidney Skin and fat Liver 200 lg/kg Milk 500 lg/kg Muscle 500 lg/kg 500 lg/kg Fat Liver 1 000 lg/kg Kidney 100 lg/kg Milk 100 lg/kg Muscle 100 lg/kg 200 lg/kg Fat Liver 1 000 lg/kg Kidney 500 lg/kg Milk 500 lg/kg Muscle 500 lg/kg 500 lg/kg Fat Liver 5 000 lg/kg Kidney 500 lg/kg Eggs Provisional MRLs expire on 1 July 1999 Provisional MRLs expire on 1 June 2000 Provisional MRLs expire on 1 June 2000 Provisional MRLs expire on 1 June 2000 L 6 0 / 4 6 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Spectinomycin Spectinomycin Bovine Bovine, porcine, poultry Streptomycin Streptomycin Bovine, ovine Bovine, ovine, porcine, poultry Provisional MRLs expire on 1 July 2000 Provisional MRLs expire on 1 June 2000 200 lg/kg Milk 300 lg/kg Muscle 500 lg/kg 2 000 lg/kg 5 000 lg/kg Kidney Fat Liver 200 lg/kg Milk 500 lg/kg Muscle 500 lg/kg 500 lg/kg Fat Liver 1 000 lg/kg Kidney 1. 2. 6. Quinolones Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Decoquinate Decoquinate Bovine, ovine Enrofloxacin Sum of enrofloxacin and Ovine ciprofloxacin Flumequine Flumequine Bovine, ovine, porcine, chicken Marbofloxacin Marbofloxacin Bovine Salmonidae Provisional MRLs expire on 1 July 2000 Provisional MRLs expire on 1 July 1999 Provisional MRLs expire on 1 January 2000 Provisional MRLs expire on 1 July 2000 500 lg/kg Muscle 500 lg/kg 500 lg/kg 500 lg/kg Kidney Fat Liver 100 lg/kg Muscle 100 lg/kg 300 lg/kg 200 lg/kg Kidney Fat Liver 50 lg/kg Muscle 50 lg/kg Fat or skin and fat Liver 100 lg/kg 300 lg/kg Kidney 150 lg/kg Muscle and skin 150 lg/kg Muscle 50 lg/kg 150 lg/kg 150 lg/kg Kidney 75 lg/kg Milk Fat Liver 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 4 7 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Porcine 150 lg/kg Muscle 50 lg/kg 150 lg/kg 150 lg/kg Kidney Skin and fat Liver 1. 2. 9. Polymyxins Phamarcologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Colistin Colistin Bovine, ovine Bovine, ovine, porcine, chicken, rabbits Chicken 50 lg/kg Milk 150 lg/kg Muscle 150 lg/kg 150 lg/kg 200 lg/kg Kidney 300 lg/kg Fat Liver Eggs Provisional MRLs expire on 1 July 2000 1. 2. 10. Penicillins Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Penethamate Benzylpenicillin Ovine Porcine Provisional MRLs expire on 1 January 2000 Fat Liver 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney 4 lg/kg Milk 50 lg/kg Muscle 50 lg/kg 50 lg/kg 50 lg/kg Kidney Fat Liver 1. 2. 11. Florfenicol and related compounds Pharmacologically active substance(s) Florfenicol Marker residue Animal species MRLs Target tissues Other provisions Sum of florfenicol and its metabolites measured as florfenicol-amine Fish 1 000 lg/kg Muscle and skin in natural proportions Provisional MRLs expire on 1 July 2001 L 6 0 / 4 8 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 2. Antiparasitic agents 2. 1. Agents acting against endoparasites 2. 1. 2. Benzimidazoles and pro-benzimidazoles Pharmacologically active substance(s) Albendazole sulphoxide Netobimin Marker residue Animal species MRLs Target tissues Other provisions Bovine, ovine Bovine, ovine, pheasant Bovine, ovine, caprine albendazole, Sum of albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole Sum of netobimin and albendazole and meta- bolites albendazole measured as 2-amino- benzimidazole sulphone of Provisional MRLs expire on 1 January 2000 Provisional MRLs expire on 31 July 1999 100 lg/kg Milk 100 lg/kg Muscle 100 lg/kg 1 000 lg/kg Fat Liver 500 lg/kg Kidney 100 lg/kg Muscle 100 lg/kg 1 000 lg/kg Fat Liver 500 lg/kg Kidney 100 lg/kg Milk 2. 2. Agents acting against ectoparasites 2. 2. 1. Formamidines Pharmacologically active substance(s) Amitraz Marker residue Animal species MRLs Target tissues Other provisions Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz Bees 200 lg/kg Honey Provisional MRLs expire on 1 July 1999 2. 2. 2. Iminophenyl thiazolidine derivative Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Cymiazole Cymiazole Bees 1 000 lg/kg Honey Provisional MRLs expire on 1 July 1999 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 4 9 2. 2. 3. Pyretrin and pyrethroids Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Cyfluthrin Cyfluthrin Bovine Provisional MRLs expire on 1 January 2001 10 lg/kg Muscle 50 lg/kg 10 lg/kg 10 lg/kg Kidney 20 lg/kg Milk Fat Liver provisions in Council Further Directive to be 94/29/EC are observed (OJ L 189, 23. 7. 1994, p. 67) 2. 2. 4. Organophosphates Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Azamethiphos Azamethiphos Salmonidae 100 lg/kg Muscle and skin in Provisional MRLs expire on 1 June 1999 natural proportions 2. 2. 5. Acyl urea derivates Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Teflubenzuron Teflubenzuron Salmonidae 500 lg/kg Muscle and skin in Provisional MRLs expire on 1 July 1999 natural proportions 2. 3. Agents acting against endo- and ectoparasites 2. 3. 1. Avermectins Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Moxidectin Moxidectin Equidae 50 lg/kg Muscle 500 lg/kg 100 lg/kg 50 lg/kg Kidney Fat Liver Provisional MRLs expire on 1 January 2000 L 6 0 / 5 0 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s 9. 3. 1 9 9 9 Agents acting on the nervous system Agents acting on the autonomic nervous system 3. 3. 2. 3. 2. 1. b2 sympathomimetic agents Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Clenbuterol hydrochloride Clenbuterol Bovine Indication: parturient cows solely for tocolysis in Equidae Indications: tocolysis and the treatment of respiratory ailments Anti-inflammatory agents 5. 5. 1. Nonsteroidal anti-inflammatory agents 5. 1. 1. Arylpropionic acid derivative Liver 0,1 lg/kg Muscle 0,5 lg/kg 0,5 lg/kg Kidney 0,05 lg/kg Milk 0,1 lg/kg Muscle 0,5 lg/kg 0,5 lg/kg Kidney Liver Provisional MRLs expire on 1 July 2000 Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Carprofen Carprofen Bovine Equidae Provisional MRLs expire on 1 January 2000 Fat Liver 500 lg/kg Muscle 500 lg/kg 1 000 lg/kg 1 000 lg/kg Kidney 50 lg/kg Muscle 100 lg/kg 1 000 lg/kg 1 000 lg/kg Kidney Fat Liver 5. 1. 2. Enolic acid derivates Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions Meloxicam Meloxicam Bovine 25 lg/kg Muscle 60 lg/kg 35 lg/kg Kidney Liver Provisional MRLs expire on 1 January 2000 9. 3. 1 9 9 9 E N O f f i c i a l J o u r n a l o f t h e E u r o p e a n C o m m u n i t i e s L 6 0 / 5 1 L 60/52 EN Official Journal of the European Communities 9. 3. 1999 LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH NO MAXIMUM LEVELS CAN BE FIXED ANNEX IV Pharmacologically active substance(s) Aristolochia spp. and preparations thereof Chloramphenicol Chloroform Chlorpromazine Colchicine Dapsone Dimetridazole Metronidazole Nitrofurans (including furazolidone) Ronidazole


title: Komission asetus (EY) N:o 484/1999, annettu 4 päivänä maaliskuuta 1999, viljojen tukeen sovellettavan korjauskertoimen vahvistamisesta

eurovoc_concepts:
cereals
export refund

formats: pdf print

text: L 57/16 FI Euroopan yhteis(cid:148)jen virallinen lehti 5. 3. 1999 KOMISSION ASETUS (EY) N:o 484/1999, annettu 4 p(cid:132)iv(cid:132)n(cid:132) maaliskuuta 1999, viljojen tukeen sovellettavan korjauskertoimen vahvistamisesta EUROOPAN YHTEIS(cid:153)JEN KOMISSIO, joka ottaa huomioon Euroopan yhteis(cid:148)n perustamissopi- muksen, ottaa huomioon vilja-alan yhteisest(cid:132) markkinaj(cid:132)rjestelyst(cid:132) 30 p(cid:132)iv(cid:132)n(cid:132) kes(cid:132)kuuta 1992 annetun neuvoston asetuksen (ETY) N:o 1766/92 (1), sellaisena kuin se on viimeksi muutettuna komission asetuksella (EY) N:o 923/96 (2), ja erityisesti sen 13 artiklan 8 kohdan, sek(cid:132) katsoo, ett(cid:132) asetuksen (ETY) N:o 1766/92 13 artiklan 8 kohdan nojalla lupahakemuksen j(cid:132)tt(cid:148)p(cid:132)iv(cid:132)n(cid:132) sovellettavaa vientitukea on sovellettava hakemuksesta t(cid:132)m(cid:132)n luvan voimassaoloaikana toteutuvaan vientiin; t(cid:132)ss(cid:132) tapauksessa tukeen on sovellet- tava korjauskerrointa, neuvoston asetuksen (ETY) N:o 1766/92 soveltamista koskevista tietyist(cid:132) yksityiskohtaisista s(cid:132)(cid:132)nn(cid:148)ist(cid:132) vientitu- toteutettavien kien my(cid:148)nt(cid:132)misen ja h(cid:132)iri(cid:148)tilanteessa toimenpiteiden osalta vilja-alalla 29 p(cid:132)iv(cid:132)n(cid:132) kes(cid:132)kuuta 1995 annetussa komission asetuksessa (EY) N:o 1501/ 95 (3), sellaisena kuin se on viimeksi muutettuna asetuk- sella (EY) N:o 2513/98 (4), sallitaan asetuksen (ETY) N:o 1766/92 1 artiklan 1 kohdan c alakohdassa tarkoitettuja tuotteita koskevan korjauskertoimen vahvistaminen; t(cid:132)m(cid:132) kerroin on laskettava ottaen huomioon asetuksen (EY) N:o 1501/95 1 artiklassa esitetyt tek¶(cid:132)t, maailmanmarkkinatilanne erityisvaatimukset voivat eriytt(cid:132)mist(cid:132) m(cid:132)(cid:132)r(cid:132)paikan mukaan, tai edellytt(cid:132)(cid:132) tiettyjen markkinoiden korjauskertoimen korjauskerroin ja tuki on vahvistettava samaa menettely(cid:132) noudattaen; kerrointa voidaan muuttaa kahden vahvista- misen v(cid:132)lisen(cid:132) aikana, edell(cid:132) mainituista s(cid:132)(cid:132)nn(cid:148)ksist(cid:132) seuraa, ett(cid:132) korjauskerroin ja on vahvistettava t(cid:132)m(cid:132)n asetuksen liitteen mukaisesti, t(cid:132)ss(cid:132) asetuksessa s(cid:132)(cid:132)detyt toimenpiteet ovat viljan hallin- tokomitean lausunnon mukaiset, ON ANTANUT T(cid:142)M(cid:142)N ASETUKSEN: 1 artikla Asetuksen (ETY) N:o 1766/92 1 artiklan 1 kohdan a, b ja c alakohdassa tarkoitettujen tuotteiden, lukuun ottamatta maltaita, ennakolta vahvistettuihin vientitukiin sovellet- tava korjauskerroin vahvistetaan liitteess(cid:132). 2 artikla T(cid:132)m(cid:132) asetus tulee voimaan 5 p(cid:132)iv(cid:132)n(cid:132) maaliskuuta 1999. T(cid:132)m(cid:132) asetus on kaikilta osiltaan velvoittava, j(cid:132)senvaltioissa. ja sit(cid:132) sovelletaan sellaisenaan kaikissa Tehty Brysseliss(cid:132) 4 p(cid:132)iv(cid:132)n(cid:132) maaliskuuta 1999. Komission puolesta Franz FISCHLER Komission j(cid:132)sen (1) EYVL L 181, 1. 7. 1992, s. 21 (2) EYVL L 126, 24. 5. 1996, s. 37 (3) EYVL L 147, 30. 6. 1995, s. 7 (4) EYVL L 313, 21. 11. 1998, s. 16 5. 3. 1999 FI Euroopan yhteis(cid:148)jen virallinen lehti L 57/17 viljojen tukeen sovellettavan korjauskertoimen vahvistamisesta 4 p(cid:132)iv(cid:132)n(cid:132) maaliskuuta 1999 annettuun komission asetukseen LIITE Tuotekoodi M(cid:132)(cid:132)r(cid:132)paikka (1) Kuluva 3 1. jakso 4 2. jakso 5 3. jakso 6 4. jakso 7 5. jakso 8 6. jakso 9 (EUR/t) — 0 — 0 0 — 0 0 — 0 — 0 0 — — — 0 0 0 0 0 — — 0 — — 0 0 — 0 — — –1,00 — 0 0 — –25,00 0 — 0 — 0 –1,00 — — — 0 0 0 0 0 — — 0 — — 0 0 — 0 — — –2,00 — 0 0 — –25,00 0 — 0 — 0 –2,00 — — — 0 0 0 0 0 — — 0 — — 0 0 — 0 — — –2,00 — 0 0 — –35,00 –10,00 — 0 — 0 –3,00 — — — 0 0 0 0 0 — — 0 — — –10,00 –10,00 — 0 — — 0 — –10,00 0 — –25,00 0 — 0 — 0 –4,00 — — — 0 0 0 0 0 — — 0 — — 0 0 — 0 — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — 1001 10 00 9200 1001 10 00 9400 1001 90 91 9000 1001 90 99 9000 1002 00 00 9000 1003 00 10 9000 1003 00 90 9000 1004 00 00 9200 1004 00 00 9400 1005 10 90 9000 1005 90 00 9000 1007 00 90 9000 1008 20 00 9000 1101 00 11 9000 1101 00 15 9100 1101 00 15 9130 1101 00 15 9150 1101 00 15 9170 1101 00 15 9180 1101 00 15 9190 1101 00 90 9000 1102 10 00 9500 1102 10 00 9700 1102 10 00 9900 1103 11 10 9200 1103 11 10 9400 1103 11 10 9900 1103 11 90 9200 1103 11 90 9800 — 01 — 01 01 — 03 02 — 01 — 04 02 — — — 01 01 01 01 01 — — 01 — — 01 01 — 01 — (1) M(cid:132)(cid:132)r(cid:132)paikat ovat: 01 kaikki kolmannet maat, 02 muut kolmannet maat, 03 Yhdysvallat, Kanada ja Meksiko, 04 Sueitsi, Liechtenstein. Huom. Alueet m(cid:132)(cid:132)ritell(cid:132)(cid:132)n komission asetuksessa (ETY) N:o 2145/92, sellaisena kuin se on muutettuna (EYVL L 214, 30. 7. 1992, s. 20)


title: WRITTEN QUESTION No. 442/99 by Glyn FORD Harp seals

eurovoc_concepts:
Greenland
marine mammal
protection of animals

formats: html pdf print

text: C 341/114 Official Journal of the European Communities EN 29. 11. 1999 (1999/C 341/159) WRITTEN QUESTION E-0441/99 by Glyn Ford (PSE) to the Commission (4 March 1999) Subject: Human rights (cid:21) Egypt Is the Commission aware of the mass detention and torture of Egyptian Christians from the El-Kosheh village in Sohag Governate, upper Egypt? If so, does the Commission intend to make representations to the Egyptian authorities about this? Answer given by Mr Marín on behalf of the Commission (29 March 1999) The Commission is aware of the controversy surrounding recent events in El-Kosheh (Sohag Governorate; Egypt) and the alleged maltreatment of Christian villagers by the local police. The events have been reported in both the European and Egyptian press and were the subject of extensive analysis by the Egyptian organisation of human rights and other human rights organisations. The head of the delegation of the Commission in Egypt, together with his colleagues of the Member States, has followed this and other similar issues carefully and the government of Egypt is well aware of the importance that the Union attaches to the respect of human rights. On the basis of facts presently known to the Commission, there appears to be little evidence for the allegations in some quarters that the events in El-Kosheh were essentially or exclusively religious in nature. However, every allegation is handled on its own merits. The Commission, in the framework of the common foreign and security policy, does not hesitate to raise specific issues with the relevant Egyptian authorities in coordination with the Member States. (1999/C 341/160) WRITTEN QUESTION E-0442/99 by Glyn Ford (PSE) to the Commission (4 March 1999) Subject: Harp seals Is the Commission aware of the number of mutilated Harp seals recovered from the Archangel area of the White Sea in Russia? Answer given by Mr van den Broek on behalf of the Commission (26 March 1999) The Commission is unfortunately not aware of the fact put forward by the Honourable Member and has no information at its disposal on the matter. (1999/C 341/161) WRITTEN QUESTION E-0445/99 by José Valverde López (PPE) to the Commission (4 March 1999) Subject: Eradicating poliomyelitis The World Health Organization has set itself the goal of eradicating poliomyelitis before the year 2000, which will require approximately US$ 370 million for the necessary vaccination campaigns. What cooperation programmes is the European Union engaged on with the developing countries to eradicate this disease?


title: Verordening (EG) nr. 480/1999 van de Commissie van 4 maart 1999 houdende tijdelijke afwijking van Verordening (EG) nr. 1445/95 houdende uitvoeringsbepalingen voor de invoer- en uitvoercertificatenregeling in de sector rundvlees

eurovoc_concepts:
beef
derogation from EU law
export licence
import licence

text: 5. 3. 1999 NL Publicatieblad van de Europese Gemeenschappen L 57/7 VERORDENING (EG) Nr. 480/1999 VAN DE COMMISSIE van 4 maart 1999 houdende t¶del¶ke afw¶king van Verordening (EG) nr. 1445/95 houdende uitvoeringsbepalingen voor de invoer- en uitvoercertificatenregeling in de sector rundvlees DE COMMISSIE VAN DE EUROPESE GEMEENSCHAPPEN, Gelet op het Verdrag tot oprichting van de Europese Gemeenschap, Gelet op Verordening (EEG) nr. 805/68 van de Raad van 27 juni 1968 houdende een gemeenschappel¶ke ordening der markten in de sector rundvlees (1), laatstel¶k gew¶zigd b¶ Verordening (EG) nr. 1633/98 (2), en met name op de artikelen 9 en 13, Overwegende dat in artikel 10, lid 1, van Verordening (EG) nr. 1445/95 van de Commissie van 26 juni 1995 houdende uitvoeringsbepalingen voor de invoer- en uitvoercertificatenregeling in de sector rundvlees en tot intrekking van Verordening (EEG) nr. 2377/80 (3), laat- stel¶k gew¶zigd b¶ Verordening (EG) nr. 2648/98 (4), is bepaald dat de uitvoercertificaten worden afgegeven op de v¶fde werkdag na de dag waarop de aanvraag is ingediend, tenz¶ de Commissie in die periode een b¶zondere maat- regel heeft genomen; Overwegende dat, rekening houdend met de feestdagen in 1999 en met de onregelmatige versch¶ning van het Publi- catieblad gedurende die dagen, deze bedenkt¶d van v¶f dagen te kort is voor een goed marktbeheer en t¶del¶k dient te worden verlengd tot zeven dagen; Overwegende dat de in deze verordening vervatte maatre- gelen in overeenstemming z¶n met het advies van het Comit(cid:130) van beheer voor rundvlees, HEEFT DE VOLGENDE VERORDENING VASTGESTELD: Artikel 1 In afw¶king van artikel 10, lid 1, van Verordening (EEG) nr. 1445/95 worden in de periode van: — 29 tot en met 31 maart 1999, — 10 tot en met 12 mei 1999, — 28 en 29 oktober 1999, — 20 tot en met 29 december 1999, de aangevraagde certificaten afgegeven op de zevende werkdag na de dag waarop de aanvraag is ingediend, tenz¶ de Commissie in die periode een van de in lid 2 van dat artikel bedoelde b¶zondere maatregelen heeft genomen. Artikel 2 Deze verordening treedt in werking op de zevende dag volgende op die van haar bekendmaking in het Publica- tieblad van de Europese Gemeenschappen. Deze verordening is verbindend in al haar onderdelen en is rechtstreeks toepassel¶k in elke lidstaat. Gedaan te Brussel, 4 maart 1999. Voor de Commissie Franz FISCHLER Lid van de Commissie (1) PB L 148 van 28. 6. 1968, blz. 24. (2) PB L 210 van 28. 7. 1998, blz. 17. (3) PB L 143 van 27. 6. 1995, blz. 35. (4) PB L 335 van 10. 12. 1998, blz. 39


title: Verordening (EG) nr. 479/1999 van de Commissie van 4 maart 1999 houdende intrekking van bepaalde verordeningen in de sector melk en zuivelproducten

eurovoc_concepts:
EC Regulation
European Commission
drafting of EU law
milk
milk product

text: 5. 3. 1999 NL Publicatieblad van de Europese Gemeenschappen L 57/5 VERORDENING (EG) Nr. 479/1999 VAN DE COMMISSIE van 4 maart 1999 houdende intrekking van bepaalde verordeningen in de sector melk en zuivelproducten DE COMMISSIE VAN DE EUROPESE GEMEENSCHAPPEN, Gelet op het Verdrag tot oprichting van de Europese Gemeenschap, Gelet op Verordening (EEG) nr. 804/68 van de Raad van 27 juni 1968 houdende een gemeenschappel¶ke ordening der markten in de sector melk en zuivelproducten (1), laatstel¶k gew¶zigd b¶ Verordening (EG) nr. 1587/96 (2), en met name artikel 6, lid 6, artikel 7, lid 5, artikel 10, lid 3, en artikel 12, lid 3, Overwegende dat verschillende wetgevende besluiten in de sector melk en zuivelproducten geen reden van bestaan meer hebben, met name als gevolg van w¶zi- gingen in de basiswetgeving en de voltooiing van wat met de vaststelling van die besluiten werd beoogd, alsmede van belangr¶ke w¶zigingen in de marktsituatie; dat het om meer duidel¶kheid en rechtszekerheid te scheppen en de zaken te vereenvoudigen, dienstig is deze wetgevende besluiten formeel in te trekken; Overwegende dat de in deze verordening vervatte maatre- gelen in overeenstemming z¶n met het advies van het Comit(cid:130) van beheer voor melk en zuivelproducten, HEEFT DE VOLGENDE VERORDENING VASTGESTELD: Artikel 1 De in de b¶lage vermelde verordeningen worden inge- trokken. Artikel 2 Deze verordening treedt in werking op de zevende dag volgende op die van haar bekendmaking in het Publica- tieblad van de Europese Gemeenschappen. Deze verordening is verbindend in al haar onderdelen en is rechtstreeks toepassel¶k in elke lidstaat. Gedaan te Brussel, 4 maart 1999. Voor de Commissie Franz FISCHLER Lid van de Commissie (1) PB L 148 van 28. 6. 1968, blz. 13. (2) PB L 206 van 16. 8. 1996, blz. 21. L 57/6 NL Publicatieblad van de Europese Gemeenschappen 5. 3. 1999 B(cid:246)LAGE — Verordening (EEG) nr. 1282/72 van de Commissie van 21 juni 1972 betreffende de verkoop van boter tegen verlaagde pr¶s aan het leger en de daarmee gel¶kgestelde eenheden (PB L 142 van 22. 6. 1972, blz. 14), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 342/89 (PB L 39 van 11. 2. 1989, blz. 19). — Verordening (EEG) nr. 1717/72 van de Commissie van 8 augustus 1972 met betrekking tot de verkoop van boter tegen verlaagde pr¶s aan instellingen en gemeenschappen zonder winstoogmerk (PB L 181 van 9. 8. 1972, blz. 11), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 3812/85 (PB L 368 van 31. 12. 1985, blz. 3). — Verordening (EEG) nr. 368/77 van de Commissie van 23 februari 1977 met betrekking tot de verkoop b¶ openbare inschr¶ving van mageremelkpoeder bestemd voor voeder voor andere dieren dan jonge kalveren (PB L 52 van 24. 2. 1977, blz. 19), laatstel¶k gew¶zigd b¶ Verordening (EG) nr. 1802/95 (PB L 174 van 26. 7. 1995, blz. 27). — Verordening (EEG) nr. 443/77 van de Commissie van 2 maart 1977 met betrekking tot de verkoop tegen vastgestelde pr¶s van mageremelkpoeder bestemd voor voeder van andere dieren dan jonge kalveren en tot w¶ziging van de Verordeningen (EEG) nr. 1687/76 en (EEG) nr. 368/77 (PB L 58 van 3. 3. 1977, blz. 16), laatstel¶k gew¶zigd b¶ Verordening (EG) nr. 1802/95. — Verordening (EEG) nr. 1844/77 van de Commissie van 10 augustus 1977 inzake de toekenning, via inschr¶ving, van b¶zondere steun voor mageremelkpoeder voor vervoedering aan andere dieren dan jonge kalveren (PB L 205 van 11. 8. 1977, blz. 11), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 1756/93 (PB L 161 van 2. 7. 1993, blz. 48). — Verordening (EEG) nr. 2793/77 van de Commissie van 15 december 1977 houdende de uitvoeringsbepa- lingen betreffende een speciale steun voor ondermelk bestemd voor voederdoeleinden, behalve voor jonge kalveren (PB L 321 van 16. 12. 1977, blz. 30), geschorst b¶ Verordening (EEG) nr. 3715/87 (PB L 349 van 12. 12. 1987, blz. 19). — Verordening (EEG) nr. 2770/79 van de Commissie van 10 december 1979 inzake de verkoop van mageremelkpoeder voor vervoedering aan kalveren en houdende w¶ziging van Verordening (EEG) nr. 1687/76 (PB L 315 van 11. 12. 1979, blz. 11), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 1802/95. — Verordening (EEG) nr. 2192/81 van de Commissie van 31 juli 1981 betreffende de toekenning van steun voor de aankoop van boter door het leger en de daarmee gel¶kgestelde eenheden van de lidstaten (PB L 213 van 1. 8. 1981, blz. 24), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 1756/93. — Verordening (EEG) nr. 2268/84 van de Commissie van 31 juli 1984 betreffende de b¶zondere verkoop van interventieboter voor uitvoer naar bepaalde bestemmingen en tot w¶ziging van Verordening (EEG) nr. 1687/76 (PB L 208 van 3. 8. 1984, blz. 35), geschorst b¶ Verordening (EEG) nr. 1645/85 (PB L 159 van 19. 6. 1985, blz. 5). — Verordening (EEG) nr. 2409/86 van de Commissie van 30 juli 1986 betreffende de verkoop van interven- tieboter bestemd voor b¶menging in mengvoeder (PB L 208 van 31. 7. 1986, blz. 29), laatstel¶k gew¶zigd b¶ Verordening (EEG) nr. 1756/93. — Verordening (EEG) nr. 2020/88 van de Commissie van 7 juli 1988 waarb¶ degenen aan wie de levering van communautaire voedselhulp is gegund, de mogel¶kheid wordt geboden om mageremelkpoeder te kopen van de interventiebureaus en waarb¶ wordt afgeweken van Verordening (EEG) nr. 2213/76 (PB L 177 van 8. 7. 1988, blz. 37), geschorst b¶ Verordening (EEG) nr. 2585/88 (PB L 230 van 19. 8. 1988, blz. 22). — Verordening (EEG) nr. 1735/89 van de Commissie van 19 juni 1989 betreffende de terugvordering b¶ uitvoer van de steun voor mageremelkpoeder bestemd voor voederdoeleinden en in mengvoeder verwerkte ondermelk (PB L 171 van 20. 6. 1989, blz. 23), geschorst b¶ Verordening (EEG) nr. 2601/90 (PB L 245 van 8. 9. 1990, blz. 11)


title: Regulamento (CE) n° 480/1999 da Comissão de 4 de Março de 1999 que derroga o Regulamento (CE) n° 1445/95 que estabelece as normas de execução do regime dos certificados de importação e de exportação no sector da carne de bovino

text: 5. 3. 1999 PT Jornal Oficial das Comunidades Europeias L 57/7 REGULAMENTO (CE) Nº 480/1999 DA COMISS(cid:212)O de 4 de Mar(cid:135)o de 1999 que derroga o Regulamento (CE) nº 1445/95 que estabelece as normas de execu(cid:135)(cid:209)o do regime dos certificados de importa(cid:135)(cid:209)o e de exporta(cid:135)(cid:209)o no sector da carne de bovino A COMISS(cid:212)O DAS COMUNIDADES EUROPEIAS, Tendo em conta o Tratado que institui a Comunidade Europeia, Tendo em conta o Regulamento (CEE) nº 805/68 do Conselho, de 27 de Junho de 1968, que estabelece a organiza(cid:135)(cid:209)o comum do mercado no sector da carne de bovino (1), com a (cid:156)ltima redac(cid:135)(cid:209)o que lhe foi dada pelo Regulamento (CE) nº 1633/98 (2), e, nomeadamente, os seus artigos 9º e 13º, Considerando que o nº 1 do artigo 10º do Regulamento (CE) nº 1445/95 da Comiss(cid:209)o, de 26 de Junho de 1995, que estabelece as normas de execu(cid:135)(cid:209)o do regime dos certificados de importa(cid:135)(cid:209)o e de exporta(cid:135)(cid:209)o no sector da carne de bovino e que revoga o Regulamento (CEE) nº 2377/80 (3), com a (cid:156)ltima redac(cid:135)(cid:209)o que lhe foi dada pelo Regulamento (CE) nº 2648/98 (4), prev(cid:136) que os certi- ficados de exporta(cid:135)(cid:209)o sejam emitidos no quinto dia (cid:156)til ap(cid:155)s o dia da apresenta(cid:135)(cid:209)o do pedido, desde que, entre- tanto, a Comiss(cid:209)o n(cid:209)o tenha tomado nenhuma medida especial; Considerando que, atendendo aos dias feriados de 1999 e (cid:133) publica(cid:135)(cid:209)o irregular do Jornal Oficial durante esses dias, se afigura que o prazo de reflex(cid:209)o de cinco dias (cid:130) dema- siado curto para assegurar a boa gest(cid:209)o do mercado e que importa alarg(cid:145)-lo temporariamente a sete dias; Considerando que as medidas previstas no presente regu- lamento est(cid:209)o em conformidade com o parecer do Comit(cid:130) de Gest(cid:209)o da Carne de Bovino, ADOPTOU O PRESENTE REGULAMENTO: Artigo 1º Em derroga(cid:135)(cid:209)o do nº 1 do artigo 10º do Regulamento (CE) nº 1445/95, os certificados correspondentes aos pedidos apresentados durante os per(cid:146)odos de: — 29 a 31 de Mar(cid:135)o de 1999, — 10 a 12 de Maio de 1999, — 28 a 29 de Outubro de 1999, — 20 a 29 de Dezembro de 1999, devem ser emitidos no s(cid:130)timo dia (cid:156)til ap(cid:155)s o dia da apresenta(cid:135)(cid:209)o do pedido, desde que, entretanto, n(cid:209)o tenha sido tomada pela Comiss(cid:209)o nenhuma das medidas espe- ciais referidas no nº 2. Artigo 2º O presente regulamento entra em vigor no s(cid:130)timo dia seguinte ao da sua publica(cid:135)(cid:209)o no Jornal Oficial das Comunidades Europeias. O presente regulamento (cid:130) obrigat(cid:155)rio em todos os seus elementos e directamente aplic(cid:145)vel em todos os Estados-membros. Feito em Bruxelas, em 4 de Mar(cid:135)o de 1999. Pela Comiss(cid:209)o Franz FISCHLER Membro da Comiss(cid:209)o (1) JO L 148 de 28. 6. 1968, p. 24. (2) JO L 210 de 28. 7. 1998, p. 17. (3) JO L 143 de 27. 6. 1995, p. 35. (4) JO L 335 de 10. 12. 1998, p. 39


title: WRITTEN QUESTION No. 444/99 by José VALVERDE LÓPEZ Adjusting the definition of small and medium enterprises

eurovoc_concepts:
access to information
accounting
balance sheet
derogation from EU law
publication of accounts
small and medium-sized enterprises

text: C 348/70 Official Journal of the European Communities EN 3. 12. 1999 Answer given by Mr Santer on behalf of the Commission (1 April 1999) The obligation for American companies to declare their lobbying activities, including the amount they spend on such activities, derives from the registration system which applies to all organisations lobbying US federal bodies. This registration system is not compatible with the Commission’s approach, which is based on openness to all interest groups and guarantees them equal treatment while recommending that they apply a system of self- regulation. This being so, the Commission has no plans to adopt measures which would require a radical change of policy. (1999/C 348/088) WRITTEN QUESTION E-0444/99 by José Valverde López (PPE) to the Commission (4 March 1999) Subject: Adjusting the definition of small and medium enterprises The Commission has submitted a proposal for a directive adjusting the financial thresholds used in defining small and medium enterprises in the context of European directives on accounting. The proposal will allow the Member States to establish exceptions with regard to obligatory financial information for a larger number of SMEs. What social partners and associations of SMEs and artisans were contacted in the course of preparing this proposal? Answer given by Mr Monti on behalf of the Commission (8 April 1999) The Fourth Council Directive 78/660/EC) of 25 July 1978 on the annual accounts of certain types of companies (1) allows Member States to exempt small and medium-sized companies from certain requirements of the Directive. Small and medium-sized companies are defined for the purposes of the Directive by reference to three criteria, i. e. balance sheet total, net turnover and average number of employees. The balance sheet total and net turnover amounts are expressed in Euro. In accordance with Article 53(2) of the Directive every five years the Council, acting on a proposal from the Commission, is to examine and, if need be, revise the amounts expressed in Euro. As the Directive stipulates that this five-yearly revision has to take place ‘in the light of economic and monetary trends in the Community’ there is no need for special consultation of social partners and associations of small and medium-sized enterprises (SMEs). The revision is of a purely technical nature and is based upon statistical figures. (1) OJ L 222, 14. 8. 1978. (1999/C 348/089) WRITTEN QUESTION E-0450/99 by Giuseppe Rauti (NI) to the Commission (5 March 1999) Subject: Collapse of the ancient walls of Viterbo Controversy has arisen in Viterbo over reconstruction of the ancient walls, two stretches of which, measuring some dozens of metres, collapsed in January and March 1997. After so many months the reconstruction has


title: SCHRIFTLICHE ANFRAGE Nr. 447/99 von José VALVERDE LÓPEZ Abteilung für Lebensmittelanalyse des Umweltinstituts (Ispra)

eurovoc_concepts:
European Environment Agency
Italy
chemical product
food additive
food inspection
foodstuff
genetically modified organism
prepared foodstuff
product safety
research body

text: C 370/42 Amtsblatt der Europäischen Gemeinschaften DE 21. 12. 1999 kann, obwohl sie durch einen nationalen Text in der erforderlichen Weise umgesetzt worden ist, könnte die Kommission einschreiten. Doch wird aus den geschilderten Fakten nicht ersichtlich, ob es sich im vorliegenden Fall um ein auf Dauer vorschriftswidriges Verhalten der griechischen Behörden oder vielmehr um einen Einzelfall handelt. Die Kommission hat die in Griechenland und in Italien zur Umsetzung der Richtlinie erlassenen Rechts- vorschriften geprüft und zumindest hinsichtlich der Probleme, die Gegenstand dieser Anfrage sind, keine Unregelmäßigkeiten festgestellt. Im übrigen haben die Mitgliedstaaten nach Artikel 56 der Richtlinie 92/49/ EWG dafür zu sorgen, daß gegen Entscheidungen, die bezüglich eines Versicherungsunternehmens auf- grund von gemäß dieser Richtlinie erlassenen Rechts- und Verwaltungsvorschriften ergehen, vor Gericht ein Rechtsbehelf eingelegt werden kann. Im vorliegenden Fall hat das betroffene Versicherungsunternehmen Zweifel an der Rechtmäßigkeit insbe- sondere des Verfahrens, das von den italienischen Behörden gegen das Unternehmen angestrengt worden ist, aber auch des Widerrufs seiner Zulassung. Alle Fragen zu dieser Rechtssache müssen durch Einlegung eines gerichtlichen oder außergerichtlichen Rechtsbehelfs vor den zuständigen griechischen und italieni- schen Instanzen und auf der Grundlage des griechischen und italienischen Rechts geklärt werden. (1999/C 370/053) SCHRIFTLICHE ANFRAGE E-0426/99 von Mary Banotti (PPE) an die Kommission (1. März 1999) Betrifft: Charterflüge Erwägt die Kommission im Anschluß an ihre Antwort auf die schriftliche Anfrage E-3115/98 (1), die Bestimmungen der Richtlinie 90/314/EWG (2) des Rates so auszuweiten, daß Pauschalreisende gegen große Verspätungen bei Charterflügen geschützt werden? Welche Entschädigung steht den Verbrauchern nach Auffassung der Kommission für derart große Verspätungen zu? (1) ABl. C 142 vom 21. 5. 1999, S. 86. (2) ABl. L 158 vom 23. 6. 1990, S. 59. Antwort von Herrn Kinnock im Namen der Kommission (4. Mai 1999) Auch wenn Verspätungen in der Richtlinie 90/314/EWG des Rates vom 13. Juni 1990 über Pauschalreisen nicht ausdrücklich genannt sind, haften grundsätzlich die Reiseveranstalter gegenüber Pauschalreisenden für Abweichungen in dem angebotenen Dienst, worunter auch Verspätungen fallen. Daher sind derzeit keine weiteren Maßnahmen vorgesehen. Bei begründeten Beschwerden hängt der zu zahlende Betrag von den jeweiligen Umständen ab. Die Kommission ist daher nicht in der Lage, diesen Teil der Frage genauer zu beantworten. Darüber hinaus regelt auch das Warschauer Abkommen die Haftung von Luftfahrtunternehmen bei Verspätungen. In Artikel 19 heißt es: „Der Luftfrachtführer hat den Schaden zu ersetzen, der durch Verspätung bei der Luftbeförderung von Reisenden, Gepäck oder Gütern entsteht. “ (1999/C 370/054) SCHRIFTLICHE ANFRAGE E-0447/99 von José Valverde López (PPE) an die Kommission Betrifft: Abteilung für Lebensmittelanalyse des Umweltinstituts (Ispra) (4. März 1999) Das Europäische Umweltinstitut Ispra verfügt über eine für die Analyse von Lebensmitteln zuständige Abteilung, die die Qualität von Lebensmittelzutaten, Zusätzen und allgemein von chemischen Stoffen prüft, die bei der Herstellung von Lebensmitteln verwendet werden. Kann die Kommission Auskunft über die Arbeitsweise dieser Abteilung im Jahre 1998 erteilen?


title: SCHRIFTLICHE ANFRAGE Nr. 446/99 von José VALVERDE LÓPEZ Welthandelsorganisation

eurovoc_concepts:
State aid
United States
World Trade Organisation
agricultural market
aid to agriculture
control of State aid

text: 29. 11. 1999 DE Amtsblatt der Europäischen Gemeinschaften C 341/115 Antwort von Herrn Pinheiro im Namen der Kommission (16. April 1999) Die Gemeinschaft leistet bei Impfkampagnen, vor allem in Afrika, bereits umfangreiche Hilfe durch die Lieferung von wichtigen Impfstoffen, besonders Polio-Impfstoff, sowie durch die Organisation und Ver- besserung von Impfkampagnen in Basisgesundheits-einrichtungen. Es gibt ein Sonderprogramm zur „Förde- rung einer unabhängigen Impfpolitik“ in acht Sahel-Ländern (9,5 Millionen €) mit dem Ziel, die Impfquote bei Kindern und jungen Frauen zu erhöhen und die Abhängigkeit der Staaten von externen Geldgebern für die erweiterten Impfprogramme zu verringern, wobei vor allem darauf hingearbeitet wird, in den Gesundheits- budgets der Staaten eine Haushaltslinie hierfür einzurichten. An der Finanzierung der ersten Strategie des weltweiten Programms zur Ausrottung der Kinderlähmung (GPEP) ist die Gemeinschaft aktiv beteiligt durch die Unterstützung von Basisgesundheitseinrichtungen in 32 Ländern südlich der Sahara (über 250 Mio. € im Rahmen des 7. Europäischen Entwicklungsfonds (EEF)) sowie durch Strukturanpassungshilfe-Programme zur Gegenfinanzierung vorrangiger Haushaltslinien für das Gesundheitswesen (über 458 Mio. € im Rahmen des 7. EEF). Auf besonderen Antrag der nationalen Behörden konnte die Gemeinschaft einige zusätzliche Ausgaben im Zusammenhang mit dem GPEP finanzieren. In diesem Fall müssen die Ausgaben in den staatlichen Gesundheitsbudgets eingesetzt sein. Außerdem unter- stützt die Gemeinschaft in enger Zusammenarbeit mit dem Regionalbüro der Weltgesundheitsorganisation (WHO) für Afrika den Aufbau eines epidemiologischen Überwachungsnetzes in Westafrika (Etat 500. 000 €), womit ein wichtiger Beitrag zur vierten Strategie des GPEP geleistet wird. Im übrigen führt die Gemeinschaft mit der WHO Gespräche über weitere Möglichkeiten der Zusammenarbeit. (1999/C 341/162) SCHRIFTLICHE ANFRAGE E-0446/99 von José Valverde López (PPE) an die Kommission (4. März 1999) Betrifft: Welthandelsorganisation Trotz des FAIR-act (Freedom to Farm act) von 1996, demzufolge Subventionen an amerikanische Landwirte schrittweise abgebaut werden sollen, zahlten die US 1998 Direktbeihilfen in Höhe von über 6 Milliarden Dollar. Hat die Kommission die Absicht, das von der WTO vorgesehene Schiedsverfahren in Anspruch zu nehmen? Antwort von Herrn Fischler im Namen der Kommission (12. April 1999) Die Mitglieder der Welthandelsorganisation (WTO) haben sich verpflichtet, die internen Agrarstützungen nach einem genau festgelegten Schema abzubauen. Für Subventionen, die die spezifischen Kriterien des Überein- kommens über die Landwirtschaft H die sogenannten „Green-box“- und „Blue-box“-Maßnahmen H erfüllen, gilt diese Abbaupflicht jedoch nicht. Aus den vorliegenden Informationen geht nicht hervor, daß die Vereinigten Staaten Beihilfen gewähren, die zu den vereinbarten Kriterien im Widerspruch stehen oder über ihre Verpflichtungen hinausgehen. Dessen ungeachtet müssen die Vereinigten Staaten ihre Subventionen der WTO notifizieren, woraufhin die Gemeinschaft eingehend prüfen wird, ob die notifizierten Subventionen mit den geltenden WTO-Vorschriften in Einklang stehen. (1999/C 341/163) SCHRIFTLICHE ANFRAGE E-0456/99 von Concepció Ferrer (PPE) an die Kommission (5. März 1999) Betrifft: Zollunion mit der Türkei Zur Durchführung von Maßnahmen zur Förderung der wirtschaftlichen und sozialen Entwicklung der Türkei im Rahmen der Strategie für die Annäherung und die Stärkung der Beziehungen mit der Türkei hat das Europäische Parlament am 17. September 1998 eine Entschließung zur Zollunion angenommen (A4-0251/ 98) (1)


title: INTERROGAZIONE SCRITTA n. 445/99 dell'on. José VALVERDE LÓPEZ Eradicazione della poliomielite

eurovoc_concepts:
EDF
EU financing
West Africa
World Health Organisation
developing countries
disease prevention
health policy
international cooperation
sub-Saharan Africa
vaccination

text: C 341/114 Gazzetta ufficiale delle Comunità europee IT 29. 11. 1999 (1999/C 341/159) INTERROGAZIONE SCRITTA E-0441/99 di Glyn Ford (PSE) alla Commissione (4 marzo 1999) Oggetto: Diritti umani in Egitto È a conoscenza la Commissione degli arresti di massa e delle torture di cui sono vittime gli abitanti di fede cristiana del villaggio di El-Kosheh, nel governatorato di Sohag, nell’Alto Egitto? In caso affermativo, intende la Commissione protestare presso le autorità egiziane? Risposta data dal signor Marín in nome della Commissione (29 marzo 1999) La Commissione è a conoscenza della controversia relativa agli eventi verificatisi di recente ad El-Kosheh (governatorato di Sohag, Egitto) e del presunto maltrattamento di abitanti cristiani del villaggio da parte della polizia locale. Gli eventi sono stati riferiti dalla stampa sia europea che egiziana e sono stati analizzati approfonditamente dalle organizzazioni di difesa dei diritti umani egiziane e di altri paesi. Il capo della delegazione della Commissione in Egitto, insieme ai suoi colleghi degli Stati membri, ha seguito attentamente questo ed altri casi analoghi e il governo egiziano è consapevole dell’importanza che l’Unione attribuisce al rispetto dei diritti umani. In base ai fatti attualmente a conoscenza della Commissione, le asserzioni formulate in alcuni ambienti secondo cui gli eventi di El-Kosheh sarebbbero stati essenzialmente o esclusivamente di carattere religioso, non sembrano essere sufficientemente fondate. Tuttavia, ogni asserzione è verificata individualmente. Nel quadro della politica estera e di sicurezza comune la Commissione non esita a sollevare questioni specifiche presso le competenti autorità egiziane di concerto con gli Stati membri. (1999/C 341/160) INTERROGAZIONE SCRITTA E-0442/99 di Glyn Ford (PSE) alla Commissione (4 marzo 1999) Oggetto: Foche groenlandiche È a conoscenza la Commissione del numero di foche groenlandiche mutilate che vengono recuperate nella regione di Arcangelo, nel Mar Bianco russo? Risposta data dal signor Van den Broek in nome della Commissione (26 marzo 1999) Purtroppo la Commissione non è al corrente della situazione cui fa riferimento l’onorevole parlamentare e non dispone di informazioni in merito. (1999/C 341/161) INTERROGAZIONE SCRITTA E-0445/99 di José Valverde López (PPE) alla Commissione (4 marzo 1999) Oggetto: Eradicazione della poliomielite L’Organizzazione mondiale della sanità si è posta come obiettivo l’eradicazione della poliomielite entro il 2000, il che presuppone stanziamenti per circa 370 milioni di dollari da destinare alle campagne di vaccinazione. Può la Commissione indicare quali sono i programmi di cooperazione con i paesi in via di sviluppo che l’Unione europea sta portando avanti per eradicare tale malattia?